Sunbeam Capital Management’s AbbVie ABBV Stock Holding History

Sunbeam Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.11M	Sell	4,227 -347	-8%	-$89K	0.51%	40
2026 Q2	$1.15M	Buy	4,574 +127	+3%	+$27.3K	0.53%	40
2026 Q1	$967K	Buy	4,447 +16	+0.4%	+$3.55K	0.55%	35
2025 Q4	$1.01M	Sell	4,431 -18	-0.4%	-$4.1K	0.6%	32
2025 Q3	$1.03M	Buy	4,449 +205	+5%	+$41.7K	0.64%	30
2025 Q2	$788K	Buy	4,244 +248	+6%	+$46.1K	0.6%	36
2025 Q1	$837K	Buy	3,996 +104	+3%	+$20.2K	0.8%	30
2024 Q4	$692K	Buy	+3,892	New	+$716K	0.64%	32

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Sunbeam Capital Management's ABBV Position: Q3 2026 in Review

Sunbeam Capital Management reduced its AbbVie (ABBV) stake by 7.6% in Q3 2026, selling an estimated $89K and leaving 4,227 shares worth $1.11M. The position accounts for 0.51% of the portfolio, ranked #40.

Sunbeam Capital Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.15M in Q2 2026. 2,754 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Sunbeam Capital Management held 4,227 shares of AbbVie worth $1.11M as of Q3 2026.
Sunbeam Capital Management sold 347 AbbVie shares in Q3 2026, an estimated $89K.
AbbVie made up 0.51% of Sunbeam Capital Management's portfolio in Q3 2026, its #40 holding.
Sunbeam Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
Sunbeam Capital Management's AbbVie position peaked at $1.15M in Q2 2026.
2,754 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sunbeam Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.